FDA approves Roche’s Vabysmo PFS for three leading causes of vision loss
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Fluid bed processes: drying, granulating, and coating in just one product container
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
This partnership stemmed from a successful customer-supplier relationship spanning several years.
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Plant is part of the company's CAD $30 million capital investment in the site
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Subscribe To Our Newsletter & Stay Updated